2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels

Leuk Lymphoma. 2013 Feb;54(2):408-10. doi: 10.3109/10428194.2012.701009. Epub 2012 Jul 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • 5-Methylcytosine / analogs & derivatives
  • 5-Methylcytosine / blood
  • Aged
  • Aged, 80 and over
  • Female
  • Glutarates / blood*
  • Humans
  • Isocitrate Dehydrogenase / genetics*
  • Leukemia, Myeloid, Acute / blood*
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / genetics*
  • Male
  • Mutation*
  • Neoplasm, Residual
  • Prognosis
  • Remission Induction
  • Treatment Outcome

Substances

  • Glutarates
  • alpha-hydroxyglutarate
  • 5-Methylcytosine
  • Isocitrate Dehydrogenase